KRYS - Krystal Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - KRYS (1711279)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
28 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2025-02-27
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$175.22-75019,318-4%-$131,415
2024-12-13
KRYSKrishnan SumaPres, R, D, 10%S - Sale$164.80-50,0003,153,144-2%-$8,240,023
2024-12-13
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$164.80-50,0003,153,144-2%-$8,240,023
2024-09-12
KRYSKrishnan SumaPres, R, D, 10%S - Sale$197.77-50,0003,203,144-2%-$9,888,276
2024-09-12
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$197.77-50,0003,203,144-2%-$9,888,276
2024-06-11
KRYSKrishnan SumaPres, R, D, 10%S - Sale$175.76-50,0003,253,144-2%-$8,788,062
2024-06-11
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$175.76-50,0003,253,144-2%-$8,788,062
D
2024-05-20
KRYSGangolli Julian SDirS - Sale+OE$164.13-20,0000-100%-$3,282,690
2024-03-11
KRYSKrishnan SumaPres, R, D, 10%S - Sale$170.95-50,0003,303,144-1%-$8,547,719
2024-03-11
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$170.95-50,0003,303,144-1%-$8,547,719
D
2024-02-28
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$165.88-5,00015,622-24%-$829,417
D
2024-02-28
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$166.05-7,50012,936-37%-$1,245,381
D
2024-02-26
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$136.91-8,08712,936-38%-$1,107,180
D
2024-01-22
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$130.00-2,50012,556-17%-$325,000
2023-12-11
KRYSKrishnan SumaPres, R, D, 10%S - Sale$105.67-50,0003,348,544-1%-$5,283,291
2023-12-11
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$105.67-50,0003,348,544-1%-$5,283,291
2023-09-11
KRYSKrishnan SumaPres, R, D, 10%S - Sale$127.23-50,0003,398,544-1%-$6,361,680
2023-09-11
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$127.23-50,0003,398,544-1%-$6,361,680
M
2023-06-08
KRYSJanney DanielDirS - Sale$128.36-50,000107,362-32%-$6,418,077
D
2023-06-09
KRYSOrth Andrew C.Chief Commercial OfficerS - Sale+OE$128.61-12,500100-99%-$1,607,635
2023-05-31
KRYSKrishnan SumaPres, R, D, 10%S - Sale$116.20-50,0003,448,544-1%-$5,809,889
2023-05-31
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$116.20-50,0003,448,544-1%-$5,809,889
DM
2023-05-19
KRYSRomano KathrynChief Accounting OfficerS - Sale+OE$101.60-53,42812,556-81%-$5,428,115
2023-05-19
KRYSJanney DanielDirS - Sale$95.02-50,000157,362-24%-$4,751,185
2023-05-09
KRYSJanney DanielDirS - Sale$90.74-17,100207,362-8%-$1,551,579
2023-04-19
KRYSJanney DanielDirS - Sale$90.32-7,900224,462-3%-$713,493
2023-04-17
KRYSKrishnan SumaPres, R, D, 10%S - Sale$87.65-50,0003,502,894-1%-$4,382,424
2023-04-17
KRYSKrishnan Krish SPres, CEO, 10%S - Sale$87.65-50,0003,501,601-1%-$4,382,424

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top